Showing results (131-140 of 184) with videos related to
Sort By:
Pageof 19
Breast Cancer Research : BCR|April 13, 2007
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancerChin-Yo Lin, Anders Ström, Say Li Kong, et al.Scientific Reports|January 12, 2021
Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimensYukie Kashima, Yosuke Togashi, Shota Fukuoka, et al.BMC Infectious Diseases|September 11, 2004
A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infectionLisa F P Ng, Martin L Hibberd, Eng-Eong Ooi, et al.Science Translational Medicine|July 20, 2022
Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomasFrancesca Menghi, Kalyan Banda, Pooja Kumar, et al.Neoplasia (New York, N.Y.)|December 21, 2010
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinomaNagarajan Kannan, Jian Kang, Xiangjun Kong, et al.Communications Medicine|May 23, 2022
Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infectionChee Hong Wong, Chew Yee Ngan, Rachel L Goldfeder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2026
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic ImplicationsKalyan Banda, Helen R Davies, Yogesh Kumar, et al.Cancer Research|June 19, 2004
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3Paula M Gilmore, Nuala McCabe, Jennifer E Quinn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2008
Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group BMichael P DiGiovanna, David F Stern, Susan Edgerton, et al.Molecular Systems Biology|December 24, 2010
Integrative model of genomic factors for determining binding site selection by estrogen receptor-αRoy Joseph, Yuriy L Orlov, Mikael Huss, et al.Pageof 19